Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1521757Generated: November 1, 2026

3-Amino-5-methylisoxazole → 1-Oxo-N-(3-phenyl-1,2-oxazol-5-yl)-2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]benzimidazole-8-carboxamide

https://huagongshe.com/reaction/1521757

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-Amino-5-methylisoxazoleHCID 66172—
Reactant1,1'-CarbonyldiimidazoleHCID 68263—
Reactant1,8-Diazabicyclo(5.4.0)undec-7-eneHCID 81184—
Reactant1-Oxo-2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]benzimidazole-8-carboxylic acidHCID 67236476—
SolventTetrahydrofuranHCID 8028—
Product1-Oxo-N-(3-phenyl-1,2-oxazol-5-yl)-2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]benzimidazole-8-carboxamideHCID 6832267015.1%

Reaction Steps

A solution of 1-oxo-2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]benzimidazole-8-carboxylic acid (Intermediate B, 71 mg, 0.29 mmol) and 1,1′-carbonyldiimidazole (117 mg, 0.72 mmol) in THF (10 mL) is heated to 60° C. for 1 h. The solution is cooled to room temperature and 5-methyl-3-aminoisoxazole (191 mg, 1.16 mmol) is added. After 10 min DBU (0.11 mL, 0.72 mmol) is added and the mixture heated at 60° C. for 16 h. The solvent is evaporated and H2O is added to the residue. The resulting solid is collected by filtration and is purified via preparative HPLC to afford the title compound (17 mg, 12%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09073926B2
Source datasetuspto-grants-2015_07
ORD IDord-d00844fc9eae48cdb4ae60ac5c475ce5
Source noteuspto-grants-2015_07